Works matching IS 03065251 AND DT 1983 AND VI 15 AND IP 2
1
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 167, doi. 10.1111/j.1365-2125.1983.tb01482.x
- Article
2
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 245, doi. 10.1111/j.1365-2125.1983.tb01493.x
- Marcantonio, LA;
- Auld, WH;
- Murdoch, WR;
- Purohit, R;
- Skellern, GG;
- Howes, CA
- Article
3
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 197, doi. 10.1111/j.1365-2125.1983.tb01486.x
- Desai, N;
- Taylor-Davies, A;
- Barnett, DB
- Article
4
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 267, doi. 10.1111/j.1365-2125.1983.tb01497.x
- Smith, SR;
- Gibson, R;
- Bradley, D;
- Kendall, MJ
- Article
5
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 161, doi. 10.1111/j.1365-2125.1983.tb01481.x
- Cushley, MJ;
- Tattersfield, AE;
- Holgate, ST
- Article
6
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 237, doi. 10.1111/j.1365-2125.1983.tb01492.x
- Walker, JS;
- Brown, KF;
- Shanks, CA
- Article
7
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 189, doi. 10.1111/j.1365-2125.1983.tb01485.x
- Guignard, C;
- Toi, V;
- Burckhardt, CW;
- Schelling, JL
- Article
8
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 263, doi. 10.1111/j.1365-2125.1983.tb01496.x
- Hutchings, A;
- Monie, RD;
- Spragg, B;
- Routledge, PA
- Article
9
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 221, doi. 10.1111/j.1365-2125.1983.tb01489.x
- Article
10
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 231, doi. 10.1111/j.1365-2125.1983.tb01491.x
- Dossing, M;
- Volund, A;
- Poulsen, HE
- Article
11
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 181, doi. 10.1111/j.1365-2125.1983.tb01484.x
- Boehringer, K;
- Weidmann, P;
- Link, L;
- Bianchetti, MG;
- Schiffl, H;
- Reubi, FC
- Article
12
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 259, doi. 10.1111/j.1365-2125.1983.tb01495.x
- Bittencourt, PR;
- Wade, P;
- Smith, AT;
- Richens, A
- Article
13
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 211, doi. 10.1111/j.1365-2125.1983.tb01488.x
- Reiter, C;
- Werness, PG;
- Loon, J;
- Smith, LH;
- Weinshilboum, RM
- Article
14
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 273, doi. 10.1111/j.1365-2125.1983.tb01499.x
- Fischer, C;
- Maier, K;
- Klotz, U
- Article
15
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 227, doi. 10.1111/j.1365-2125.1983.tb01490.x
- Mayersohn, M;
- Conrad, KA;
- Achari, R
- Article
16
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 173, doi. 10.1111/j.1365-2125.1983.tb01483.x
- Bennett, D;
- Davies, A;
- Davis, A
- Article
17
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 253, doi. 10.1111/j.1365-2125.1983.tb01494.x
- Newell, DR;
- Calvert, AH;
- Harrap, KR;
- McElwain, TJ
- Article
18
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 203, doi. 10.1111/j.1365-2125.1983.tb01487.x
- Article
19
- British Journal of Clinical Pharmacology, 1983, v. 15, n. 2, p. 269, doi. 10.1111/j.1365-2125.1983.tb01498.x
- Article